Overview
- Description
The company develops nano scale biotechnology solutions to support ultra high throughput therapeutic and diagnostic discovery. Solutions aim to improve the speed and scale of single cell analysis, with next-generation applications in immunoncology, autoimmune disease, and infectious disease.
- Website
- Press Release
- Country
- Ireland
- Sector
- Health Biotechnology
"RemedyBio continues to grow, following the business acceleration gained through EIC grant and blended finance funding. As our strategy evolves to look at further opportunities around our Nanoreactor Technology and Searchlight Discovery Platform, we will continue to identify and develop new efficacious therapies for hard-to-treat diseases."
Dan Crowley, CEO
